Thu, Dec 18, 2014, 4:52 AM EST - U.S. Markets open in 4 hrs 38 mins


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

leerichs 20 posts  |  Last Activity: Dec 4, 2014 12:46 PM Member since: Jan 17, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    We should cross $5 tomorrow

    by stockof2013 Dec 4, 2014 12:41 PM
    leerichs leerichs Dec 4, 2014 12:46 PM Flag

    I am intrigued at the hiring but have a question: Did IDRA go after Milano or did Milano approach IDRA?

  • Reply to

    Piper Jaffray Conference: People and Platform

    by kdreesen Dec 4, 2014 3:04 AM
    leerichs leerichs Dec 4, 2014 7:11 AM Flag

    I think the comment was intended to show respect to Sudhir, with a dose oh humility thrown in. That aside, this is a terrific team assembled that's coupled with cutting edge science. Awesome combo.

  • Reply to


    by starfe11 Nov 24, 2014 6:42 AM
    leerichs leerichs Nov 24, 2014 7:17 AM Flag

    Agree. Either the company needs to be sold or someone is needed at the helm who can get FDA approval pushed through quickly.

  • Reply to

    Janet Woodcock is a fraud!

    by teeth_4444 Nov 6, 2014 2:49 PM
    leerichs leerichs Nov 7, 2014 9:26 AM Flag

    I could understand the FDA's reluctance if etep posed a potential serious health risk to a wide portion of the population, but in this case there is a finite % of the population that can directly and immediately benefit from this drug. There is no current alternative that poses no adverse side effects and that can be safely administered. The only logical conclusion why the FDA is stonewalling must be tied to something far more sinister, and longs all know what that is.

    That is the part of this butchered equation that is so difficult to comprehend.

  • leerichs leerichs Nov 4, 2014 1:55 PM Flag

    These "public servants" are so out of touch with reality and think the citizens report to them. Nonsense.

    It is well past time to dismantle this agency, or at the very least instill strict oversight. Too much autonomy is a very bad thing and Congress needs to call their bluff. Congress and the FDA need to do their jobs. Period.

  • Reply to

    the FDA response

    by simp08801 Oct 31, 2014 8:12 AM
    leerichs leerichs Oct 31, 2014 10:34 AM Flag

    The parents and advocates need to do the following:

    Schedule a public demonstration in Washington and notify the media. And what will draw attention to yet another demonstration? By having the kids waiting for treatment parked in their wheelchairs on the sidelines cheering on the kids receiving treatment as these kids engage in a game of touch football. Let the FDA then squirm and explain how they're still not sure dystrophin is being produced in these boys.

  • Reply to

    My Recommendation to the Duchenne Moms (Part I)

    by dnn15905 Oct 30, 2014 9:55 PM
    leerichs leerichs Oct 31, 2014 7:47 AM Flag

    I've posted this before but it bears repeating. Sums up what / who we are up against............................

    You're sitting at home one day and you realize your house is on fire. So you pick up the phone.

    "Hello, Fire Dept of America (FDA), J. Woodcock speaking on a recorded line, how may I help you?"

    "Uh, yes my house is on fire and I need you guys to come over and put out the fire."

    "Well, yes, we'd love to, but can you assure us the house will actually burn down if we don't respond?"

    "Yes, I'm positive it will if you don't come over right now!"

    "Okay, please don't get upset with me. Let me run it past our crack team here. I'm sure we will be able to get something done, but even though I can make a decision, I will need to make sure the entire team is on board with the decision to assist you. In the meantime, could you please forward information on what materials were used to construct the house, how old the house is, any comparative houses like yours in the neighborhood that experienced similar fires, and oh, throw in some information on houses that haven't burned so we may be able to make the correct decision. And as soon as you get the info assembled we will call you in to review the paperwork and make sure everything is in proper order. And thanks for calling the Fire Dept of America. Have a nice day."

  • Reply to

    "You Can't Hit A Moving Target"

    by greyzone513 Oct 28, 2014 3:06 PM
    leerichs leerichs Oct 28, 2014 3:18 PM Flag

    Dramatic action is what is called for. These parents and their long-suffering boys have been kicked in the gut and now need to make a statement that this type of behavior is not going to be tolerated any longer. You can't negotiate with unreasonable people. Expecting the FDA to do the right thing is like the definition of insanity, which is doing the same thing over and over but expecting a different result.

  • Reply to

    AA effectively does not exist

    by greyzone513 Oct 28, 2014 11:31 AM
    leerichs leerichs Oct 28, 2014 1:51 PM Flag

    Do you really trust the FDA to do the right thing?

  • Reply to

    AA effectively does not exist

    by greyzone513 Oct 28, 2014 11:31 AM
    leerichs leerichs Oct 28, 2014 1:18 PM Flag

    While I think it is unreasonable to hold CG completely accountable for this latest stiff-arm by the FDA, he is nonetheless the CEO and with leadership comes consequences. His responsibility is to MAXIMIZE the value of the company, and in that endeavor he has failed miserably. We don't really know what has gone on behind closed doors in the meetings with the FDA, but clearly there must be some friction.

    And when the ebola situation is brought into the equation, well, something just isn't right.

    I've tried to give CG the benefit of the doubt over the years, but at some point a decision must be made. Is this guy capable of getting the ball over the goal line? And as much as I dislike having to agree with others on this board calling for his dismissal or resignation, I think it is time to do so, for in mid 2015, at this point, there is much likelihood the FDA or the company will pull some other stunt that will result in additional delay. CG probably feels like Charlie Brown did when Lucy would yank the football at the last minute. Experience matters, and in this case, the company needs to get someone in there who has completed deals with the FDA, someone who has the industry respect necessary to finalize things. And don't feel too sorry for CG - his 2013 compensation with salary and options and benefits was just under $10 million.

    And as bad as longs feel today, imagine how the poor kids and parents must feel knowing the FDA is treating them like #$%$, using them as pawns in whatever game is being played. Sickening.

  • leerichs leerichs Oct 24, 2014 6:51 PM Flag

    Since you own that many shares (not) you must be aware (not) of all the SEC regs regarding insider trading being super careful about passing along info that could get you in serious trouble. Back to ignore dufus.

  • Reply to

    coin flip analogy

    by pasteur420 Oct 24, 2014 2:56 PM
    leerichs leerichs Oct 24, 2014 3:44 PM Flag

    Pasteur420 is an example of how amazing the human body is, for (s)he continues to live without a brain or a heart.

  • Reply to

    4th biopsy

    by thigrlsrk Oct 14, 2014 7:53 PM
    leerichs leerichs Oct 15, 2014 6:12 AM Flag

    The FDA has had YEARS to address this matter. Release the information, and the sooner the better.

  • Reply to

    Mand dies from Marburg virus

    by leerichs Oct 5, 2014 4:52 PM
    leerichs leerichs Oct 5, 2014 9:43 PM Flag

    And how many Ebola patients are being treated in Europe?

  • Reply to

    CDC head just shot tkmr

    by simp08801 Oct 5, 2014 6:46 PM
    leerichs leerichs Oct 5, 2014 7:17 PM Flag

    And don't for a moment think an infected individual won't try anything to get to this country. With our apparent "open border policy" and no restrictions on flights this has the potential to be very, very bad.

  • Kampala (AFP) - A hospital technician has died of the Ebola-like Marburg virus in Kampala, the Ugandan government announced on Sunday.

    This is getting pretty serious. As long as our borders remain open, flights are allowed into the US, and our healthcare system remains "free", it's reasonable to assume there will be many more Ebola cases showing up in this country, among other illnesses. Those that have the means to get to this country and are infected will make every attempt possible to get here.

  • Reply to


    by simp08801 Oct 5, 2014 4:18 PM
    leerichs leerichs Oct 5, 2014 4:43 PM Flag

    Is it possible this patient has a different strain? Is it possible our government is completely incompetent? Why does it seem SRPT is the girl at the dance nobody wants to tango with? I don't get it.

  • leerichs by leerichs Sep 26, 2014 3:06 PM Flag

    Just saw this on twitter. Someone may have already posted so if this is old, my apologies................

    ALEXANDRIA, Va., Sept. 25 -- Sarepta Therapeutics, Corvallis, Oregon, has been assigned a patent (8,835,402) developed by two co-inventors for a compound and method "for treating myotonic dystrophy." The co-inventors are Ryszard Kole, Corvallis, Oregon, and Gunnar J. Hanson, Bothell, Washington.

    The patent application was filed on Sept. 26, 2013 (14/038,314). The full-text of the patent can be found at

  • Reply to

    pleasantly surprised by todays action

    by starfe11 Sep 25, 2014 3:48 PM
    leerichs leerichs Sep 25, 2014 7:32 PM Flag

    And thanks Thig for some good and thoughtful posts. Finding nuggets on this board isn't easy.

  • Reply to

    pleasantly surprised by todays action

    by starfe11 Sep 25, 2014 3:48 PM
    leerichs leerichs Sep 25, 2014 7:31 PM Flag

    Pay very close attention to the names these clowns use. Always a very subtle change of lettering in their user name. In this case is it now starTe11 rather than the usually relentless starFe11.

13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.